CNS Delivery of Biotherapeutics for the Treatment of Neurodegenerative Diseases
Time: 2:00 pm
day: Discovery Track Day 2 PM
Details:
- Exploring methods of delivery of biotherapeutics into the CNS to enhance therapeutics efficacy of antineurodegenerative assets
- Reviewing the safety aspects in developing platform technologies for long term use in older populations
- Identifying typical scientific dogmas that need to be challenged in order to successfully develop CNS targeted biotherapeutics
- Childhood dementia and the role of the lysosome
